Director Declaration
In brief · summary, not quotable
No summary for this filing – the full text is below.
Full announcement
Select text to share a quote on X · sign in to keep highlights & notes in your OXB notes
Oxford, UK - 27 March 2025: OXB (LSE: OXB), a global quality and innovation-led cell and gene therapy CDMO, today announces that Colin Bond, Non-Executive Director has recently been appointed as a Non-Executive Director of Faron Pharmaceuticals Ltd, an AIM listed company.
Cleaned text: letterheads, contacts and legal notices removed. View the original announcement ↗ · Company filings. Not investment advice.